β-Lactam vs Non–β-Lactam Prophylaxis in Elective Colorectal Surgery

Key Points

• The study aims to determine the effectiveness of β-lactam prophylaxis in reducing surgical site infection (SSI) risk during elective colorectal surgeries.
• Cohort study design involving elective colorectal surgery procedures
• Comparison of β-lactam and non-β-lactam surgical prophylaxis
• Assessment of SSI risk associated with each prophylaxis
• Adjusted analyses to evaluate dosing and timing factors
• Patients receiving β-lactam prophylaxis showed significantly lower SSI rates
• No significant association was found between dosing and timing differences and SSI risk
• The findings suggest that β-lactam prophylaxis is advantageous in elective colorectal surgeries

Abstract